Newsroom
January 11, 2022
Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue
DURHAM, NC – January 11, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…
December 28, 2021
Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference
DURHAM, NC – December 28, 2021 – Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali,…
December 21, 2021
Bioventus Appoints Michelle McMurry-Heath to Board of Directors
DURHAM, NC – December 21, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
December 20, 2021
Bioventus Receives US FDA Clearance for BoneScalpel® Access™
DURHAM, NC – December 20, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…
November 18, 2021
Bioventus to Expand Operations and Manufacturing in Memphis
MEMPHIS, TN – November 18, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
November 15, 2021
Bioventus Announces Chief Financial Officer Transition Plan
DURHAM, NC – November 15, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing,…
November 9, 2021
Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance
DURHAM, NC – November 9, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today…
November 1, 2021
Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs
DURHAM, NC – November 1, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
October 29, 2021
Bioventus Completes the Acquisition of Misonix
DURHAM, NC – October 29, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
October 27, 2021
Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021
DURHAM, NC – October 27, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
Search News
Media Inquiries
Thomas Hill
Director of Corporate Communications
919.474.6715
[email protected]
Download Library
Corporate and Brand Logos
Download Now
Product Images
Download Now
